Tag: ATY

June 17, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NPWR

NEW YORK, June 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NET Power, Inc. (NYSE: NPWR). ...

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DoubleVerify

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In DoubleVerify To Contact Him Directly To...

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fortrea Holdings

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Fortrea To Contact Him Directly To...

INVESTIGATION ALERT: Edelson Lechtzin LLP is investigating GeneDx Holdings Corp. (NASDAQ: WGS) and Encourages Investors with Substantial Losses to Contact the Firm

NEWTOWN, Pa., June 13, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving GeneDx Holdings Corp. ("GeneDx") (NASDAQ: WGS),...

CAR Deadline: CAR Investors with Losses in Excess of $100K Have Opportunity to Lead Avis Budget Group, Inc. Securities Fraud Lawsuit

NEW YORK, June 13, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc....

VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, June 13, 2025 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action...

LPRO Investors Have Opportunity to Lead Open Lending Corporation Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, June 13, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Open...

PEPG Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against PepGen Inc.

SAN DIEGO, June 12, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise...

RCKT INVESTOR ALERT: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead the Rocket Pharmaceuticals Class Action Lawsuit

SAN DIEGO, June 12, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT)...

COMPASS DIVERSIFIED HOLDINGS (NYSE: CODI) CLASS ACTION NOTICE: Berger Montague Encourages Investors With Substantial Losses to Contact the Firm By July 8, 2025

PHILADELPHIA, June 12, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Compass Diversified Holdings ("Compass"...

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Compass Diversified Holdings (NYSE: CODI) and Encourages Investors with Substantial Losses to Contact the Firm

NEWTOWN, Pa., June 11, 2025 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating potential violations of the federal securities...

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Shelby Dermatology d/b/a Dermatologists of Birmingham Clients Whose Data May Have Been...

NEWTOWN, Pa., June 11, 2025 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Shelby...

Fortrea Holdings Inc. (FTRE) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa., June 11, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead...

OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit

NEW YORK, June 11, 2025 /PRNewswire/ -- ...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsATY

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Gala Night of the 28th Shanghai International Film Festival Held in Shanghai

Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million